Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage
Sponsor: Samsung Medical Center
Listed as NCT02673788, this observational or N/A phase trial focuses on Intracranial Hemorrhages and Mesenchymal Stem Cells and remains ongoing. Sponsored by Samsung Medical Center, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2024 — Jul 2024 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Jan 2024 [monthly]
Active Not Recruiting
▶ Show 5 earlier versions
-
May 2019 — Jan 2021 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
Jan 2019 — May 2019 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Jan 2019 [monthly]
Enrolling By Invitation
-
Apr 2018 — Jun 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Samsung Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .